Literature DB >> 12704214

Expression of MAL, an integral protein component of the machinery for raft-mediated pical transport, in human epithelia.

Mónica Marazuela1, Agustín Acevedo, Magdalena Adrados, María Angeles García-López, Miguel A Alonso.   

Abstract

The MAL protein is the only integral membrane protein identified as being an essential component of the machinery necessary for apical transport in the canine MDCK cell line, a paradigm of polarized epithelial cells. To characterize the range of human epithelia that use MAL-mediated pathways of transport, we performed an immunohistochemical survey of normal tissues using a monoclonal antibody (MAb) specific for the MAL protein. For comparison, different types of carcinoma were also analyzed. MAL, with a characteristic strong supranuclear granular distribution, was detected in specific types of normal epithelial cells throughout the respiratory system, the gastrointestinal and genitourinary tracts, and in exocrine and endocrine glands. Absorptive cells (e.g., enterocytes), and many different types of specialized secretory cells, either organized in discrete clusters (e.g., endocrine cells in the pancreas), gathered together in an endocrine gland (e.g., thyroid), interspersed with other cells in glands (e.g., parietal cells), or dispersed singly among other cells (e.g., type 2 pneumocytes) were positive for MAL. We also analyzed a series of epithelial renal and thyroid tumors and found alterations dependent on the particular histological type of tumor. These results open potential applications of the anti-MAL antibody for the characterization of neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704214     DOI: 10.1177/002215540305100512

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  14 in total

1.  Exogenous MAL reroutes selected hepatic apical proteins into the direct pathway in WIF-B cells.

Authors:  Sai Prasad Ramnarayanan; Christina A Cheng; Maria Bastaki; Pamela L Tuma
Journal:  Mol Biol Cell       Date:  2007-05-09       Impact factor: 4.138

2.  Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance.

Authors:  Shin-Ichiro Maruya; Hyung-Woo Kim; Randal S Weber; Jack J Lee; Merril Kies; Mario A Luna; John G Batsakis; Adel K El-Naggar
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection.

Authors:  Candice C Clay; J Rachel Reader; Joan E Gerriets; Theodore T Wang; Kevin S Harrod; Lisa A Miller
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

4.  Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.

Authors:  Hisani N Horne; Paula S Lee; Susan K Murphy; Miguel A Alonso; John A Olson; Jeffrey R Marks
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

5.  Effects of prenatal tobacco exposure on gene expression profiling in umbilical cord tissue.

Authors:  Naveed Hussain; Winfried Krueger; Jonathan Covault; Stephen Walsh; Henry R Kranzler; Cheryl Oncken
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

Review 6.  The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.

Authors:  Armando Rubio-Ramos; Leticia Labat-de-Hoz; Isabel Correas; Miguel A Alonso
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

7.  MAL facilitates the incorporation of exocytic uroplakin-delivering vesicles into the apical membrane of urothelial umbrella cells.

Authors:  Ge Zhou; Feng-Xia Liang; Rok Romih; Zefang Wang; Yi Liao; Jorge Ghiso; Jose L Luque-Garcia; Thomas A Neubert; Gert Kreibich; Miguel A Alonso; Nicole Schaeren-Wiemers; Tung-Tien Sun
Journal:  Mol Biol Cell       Date:  2012-02-09       Impact factor: 4.138

8.  Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.

Authors:  Guro E Lind; Terje Ahlquist; Matthias Kolberg; Marianne Berg; Mette Eknaes; Miguel A Alonso; Anne Kallioniemi; Gunn I Meling; Rolf I Skotheim; Torleiv O Rognum; Espen Thiis-Evensen; Ragnhild A Lothe
Journal:  J Transl Med       Date:  2008-03-17       Impact factor: 5.531

9.  Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer.

Authors:  Yajun Yi; Srinivas Nandana; Thomas Case; Colleen Nelson; Tatjana Radmilovic; Robert J Matusik; Karen D Tsuchiya
Journal:  Mol Cytogenet       Date:  2009-09-26       Impact factor: 2.009

10.  MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.

Authors:  T E Buffart; R M Overmeer; R D M Steenbergen; M Tijssen; N C T van Grieken; P J F Snijders; H I Grabsch; C J H van de Velde; B Carvalho; G A Meijer
Journal:  Br J Cancer       Date:  2008-11-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.